Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
Launched by FLORIDA INSTITUTE FOR HUMAN AND MACHINE COGNITION · Sep 9, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new method called biofeedback to help improve walking ability in people with Diabetic Peripheral Neuropathy (DPN), a condition that affects the nerves in the feet and can make walking difficult. The researchers want to understand how walking mechanics, like pressure on the feet while walking, can be improved with real-time feedback provided on a screen. Participants will take part in various activities, including filling out questionnaires, undergoing physical examinations, and walking on a special treadmill that tracks their movements. They will receive visual and sound cues to help them adjust their walking patterns during the session.
To join this study, participants must be able to walk 10 meters on their own without any aids and have been diagnosed with diabetes and DPN by a doctor. They'll also need to be in good enough health to walk on a treadmill for about 6 minutes. However, there are some conditions that may exclude someone from participating, such as having a recent amputation or severe cognitive or visual impairments. This trial is currently recruiting participants of all genders aged between 16 and 87. If someone is interested, they can expect a supportive environment where their walking abilities are assessed and improved with the help of innovative technology.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Able to walk 10-meters independently without an assistive device
- • Sufficient cardiovascular and musculoskeletal health to walk on a treadmill for 6 minutes at a self-selected speed
- • Diagnosis of diabetes mellitus
- • Diagnosis of diabetic peripheral neuropathy by a physician
- • Foot examination within the past 6 months documenting ambulatory status
- • Physician clearance
- Exclusion Criteria:
- • History of amputation
- • Active ulceration
- • Medial column deformity
- • Severe cognitive impairment (MoCA \< 10)
- • Severe visual impairment
- • History of Charcot osteoarthropathy
- • History of posterior muscle group lengthening
- • History of lower extremity joint replacement
- • History of lower extremity and/or foot surgery affecting walking mechanics
- • Orthopaedic problems of the lower limbs or spine due to other medical conditions (not diabetes or DPN) that limit walking or cause pain during walking
- • Improper footwear for walking and community ambulation
- • Cardiovascular or medical condition affecting ability to walk safely
- • History of unexplained dizziness or fainting in the past 2 months
- • Allergy to adhesive tape or rubbing alcohol
About Florida Institute For Human And Machine Cognition
The Florida Institute for Human and Machine Cognition (IHMC) is a leading research organization dedicated to advancing the understanding of human cognition and the development of intelligent machines. With a focus on enhancing human capabilities through innovative technologies, IHMC conducts cutting-edge research in areas such as robotics, artificial intelligence, and cognitive engineering. The institute collaborates with various academic, governmental, and industrial partners to translate scientific discoveries into practical applications, including clinical trials aimed at improving health outcomes. IHMC is committed to fostering interdisciplinary approaches that drive forward the integration of human and machine intelligence, ultimately contributing to the enhancement of human performance and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Atlanta, Georgia, United States
Pensacola, Florida, United States
Patients applied
Trial Officials
Nicole K Rendos, PhD
Principal Investigator
Florida Institute for Human and Machine Cognition
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported